These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 28927716)

  • 1. The effects of lifestyle modification and statin therapy on the circulatory markers for vascular risk in patients with epilepsy.
    Kim DW; Kim HK; Bae EK
    Epilepsy Behav; 2017 Nov; 76():133-135. PubMed ID: 28927716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of new antiepileptic drugs on circulatory markers for vascular risk in patients with newly diagnosed epilepsy.
    Kim DW; Lee SY; Shon YM; Kim JH
    Epilepsia; 2013 Oct; 54(10):e146-9. PubMed ID: 23980720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2017 Taiwan lipid guidelines for high risk patients.
    Li YH; Ueng KC; Jeng JS; Charng MJ; Lin TH; Chien KL; Wang CY; Chao TH; Liu PY; Su CH; Chien SC; Liou CW; Tang SC; Lee CC; Yu TY; Chen JW; Wu CC; Yeh HI;
    J Formos Med Assoc; 2017 Apr; 116(4):217-248. PubMed ID: 28242176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and effect of very low levels of low-density lipoprotein cholesterol on cardiovascular events.
    LaRosa JC; Pedersen TR; Somaratne R; Wasserman SM
    Am J Cardiol; 2013 Apr; 111(8):1221-9. PubMed ID: 23375731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Beyond lowering LDL cholesterol].
    Bayturan O; Utük O; Tuzcu EM
    Anadolu Kardiyol Derg; 2011 Mar; 11(2):163-7. PubMed ID: 21342860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of albuminuria and high-sensitivity C-reactive protein with the efficacy of HMG-coenzyme A reductase inhibitors for cardiovascular event prevention.
    Özyilmaz A; Boersma C; Visser ST; Postma MJ; de Jong-van den Berg LT; Lambers-Heerspink HJ; de Jong PE; Gansevoort RT
    Eur J Prev Cardiol; 2016 May; 23(8):847-55. PubMed ID: 26358992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ETC-1002 on Serum Low-Density Lipoprotein Cholesterol in Hypercholesterolemic Patients Receiving Statin Therapy.
    Ballantyne CM; McKenney JM; MacDougall DE; Margulies JR; Robinson PL; Hanselman JC; Lalwani ND
    Am J Cardiol; 2016 Jun; 117(12):1928-33. PubMed ID: 27138185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of cholesterol reducing therapy with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor on secondary prevention after myocardial infarction in Japanese patients].
    Tachibana E; Watanabe I; Nagao K; Kanmatsuse K
    J Cardiol; 2000 Apr; 35(4):277-85. PubMed ID: 10791271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol levels and statin use in patients with coronary heart disease treated in primary care settings.
    O'Connor PJ; Gray RJ; Maciosek MV; Fillbrandt KM; DeFor TA; Alexander CM; Weiss TW; Teutsch SM
    Prev Chronic Dis; 2005 Jul; 2(3):A05. PubMed ID: 15963307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
    Mora S; Ridker PM
    Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypercholesterolemia treatment patterns and low-density lipoprotein cholesterol monitoring in patients with a diagnosis of atherosclerosis in clinical practice.
    Davidson MH; Gandhi SK; Ohsfeldt RL; Fox KM
    Am J Med; 2009 Jan; 122(1 Suppl):S51-9. PubMed ID: 19110088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
    Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
    J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Models for describing relations among the various statin drugs, low-density lipoprotein cholesterol lowering, pleiotropic effects, and cardiovascular risk.
    Robinson JG
    Am J Cardiol; 2008 Apr; 101(7):1009-15. PubMed ID: 18359323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia.
    Bays HE; Davidson M; Jones MR; Abby SL
    Am J Cardiol; 2006 Apr; 97(8):1198-205. PubMed ID: 16616026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials.
    Hebert PR; Gaziano JM; Chan KS; Hennekens CH
    JAMA; 1997 Jul 23-30; 278(4):313-21. PubMed ID: 9228438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
    Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction in estimated risk for coronary artery disease after use of ezetimibe with a statin.
    Sampalis JS; Bissonnette S; Habib R; Boukas S;
    Ann Pharmacother; 2007 Sep; 41(9):1345-51. PubMed ID: 17666579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of ETC-1002 to treat hypercholesterolemia in patients with statin intolerance.
    Thompson PD; Rubino J; Janik MJ; MacDougall DE; McBride SJ; Margulies JR; Newton RS
    J Clin Lipidol; 2015; 9(3):295-304. PubMed ID: 26073387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The safety of statins in children.
    Lamaida N; Capuano E; Pinto L; Capuano E; Capuano R; Capuano V
    Acta Paediatr; 2013 Sep; 102(9):857-62. PubMed ID: 23631461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.